Effect of melatonin on jet lag after long haul flights. 1989

K Petrie, and J V Conaglen, and L Thompson, and K Chamberlain
Department of Psychology, Waikato Hospital, Hamilton, New Zealand.

OBJECTIVE To determine whether doses of the pineal hormone melatonin alleviate jet lag. METHODS Double blind, placebo controlled crossover trial. METHODS Long haul return flights from Auckland, New Zealand, to London and back. METHODS Twenty volunteers with experience of transcontinental flights (eight women and 12 men aged 28 to 68). METHODS Melatonin (or placebo) 5 mg three days before flight, during flight, and once a day for three days after arrival. METHODS Symptoms of jet lag. RESULTS Visual analogue scale for feelings of jet lag and tiredness; profile of moods states questionnaire for vigour-activity and fatigue-inertia; and retrospective ratings 10 days after arrival of sleep pattern, energy, and daytime tiredness. Feelings of jet lag were less for subjects taking melatonin (mean score 2.15 v 3.4); these subjects took fewer days than the placebo group to establish a normal sleep pattern (2.85 v 4.15), to not feel tired during the day (3.0 v 4.6), and to reach normal energy levels (3.25 v 4.7). Results for fatigue-inertia and vigour-activity were similar. For all subjects jet lag was more severe on the return (westward) than the outward (eastward) journey. CONCLUSIONS Melatonin can alleviate jet lag and tiredness after long haul flights.

UI MeSH Term Description Entries
D008297 Male Males
D008550 Melatonin A biogenic amine that is found in animals and plants. In mammals, melatonin is produced by the PINEAL GLAND. Its secretion increases in darkness and decreases during exposure to light. Melatonin is implicated in the regulation of SLEEP, mood, and REPRODUCTION. Melatonin is also an effective antioxidant.
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002940 Circadian Rhythm The regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs or environmental and physiological stimuli. Diurnal Rhythm,Nyctohemeral Rhythm,Twenty-Four Hour Rhythm,Nycthemeral Rhythm,Circadian Rhythms,Diurnal Rhythms,Nycthemeral Rhythms,Nyctohemeral Rhythms,Rhythm, Circadian,Rhythm, Diurnal,Rhythm, Nycthemeral,Rhythm, Nyctohemeral,Rhythm, Twenty-Four Hour,Rhythms, Circadian,Rhythms, Diurnal,Rhythms, Nycthemeral,Rhythms, Nyctohemeral,Rhythms, Twenty-Four Hour,Twenty Four Hour Rhythm,Twenty-Four Hour Rhythms
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005221 Fatigue The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli. Lassitude
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

K Petrie, and J V Conaglen, and L Thompson, and K Chamberlain
October 1999, Zeitschrift fur arztliche Fortbildung und Qualitatssicherung,
K Petrie, and J V Conaglen, and L Thompson, and K Chamberlain
August 1999, Australian family physician,
K Petrie, and J V Conaglen, and L Thompson, and K Chamberlain
January 2003, Archives of internal medicine,
K Petrie, and J V Conaglen, and L Thompson, and K Chamberlain
September 1999, European journal of medical research,
K Petrie, and J V Conaglen, and L Thompson, and K Chamberlain
April 2003, Health news (Waltham, Mass.),
K Petrie, and J V Conaglen, and L Thompson, and K Chamberlain
September 1986, Lancet (London, England),
K Petrie, and J V Conaglen, and L Thompson, and K Chamberlain
October 1996, The Netherlands journal of medicine,
K Petrie, and J V Conaglen, and L Thompson, and K Chamberlain
June 1998, British journal of sports medicine,
K Petrie, and J V Conaglen, and L Thompson, and K Chamberlain
February 1998, Drug and therapeutics bulletin,
K Petrie, and J V Conaglen, and L Thompson, and K Chamberlain
February 2020, Drug and therapeutics bulletin,
Copied contents to your clipboard!